Fundraising FoxPaulex Bio
La Jolla, US · Founded 2023 · 2 known investors
Find your way into Paulex Bio
Sign up to see every warm intro you have to Paulex Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Paulex Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Paulex Bio is developing an oral medicine aimed at regenerating beta cells to address the underlying cause of type 1 and type 2 diabetes. The company works in the biotech and therapeutics space with a goal of a functional cure for diabetes.
Founders & leadership
SM
Sanjuan MiguelCEO & Founder of Paulex BioSanjuan Miguel is Chief Executive Officer of Paulex Bio, which develops prevention and regeneration therapies for Type 1 and Type 2 diabetes.
Board
ER
Edgardo RayoBoard director
MH
Mohammad HayatBoard director
FL
Investors · 2
Also in the syndicate · 1
MDB Capital
Reported raises · per SEC filings
Form D private placements$18.5M disclosed across 1 round · 2025
▶$18.5MraisedDec 2025 · 163 investors · PharmaceuticalsRule 506(c)
▶$18.5MraisedDec 2025 · 163 investors · Pharmaceuticals
Rule 506(c)Officers, directors & promoters on the filing
- Edgardo RayoDirector
- Mohammad HayatDirector
- Francisco LeonDirector
- Sanjuan MiguelExecutive Officer, Director
- Offering amount
- $22.5M
- Amount sold
- $18.5M
- Sales commissions
- $1.6M
- Placement agents
- MDB Capital
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Paulex Bio went on to found or lead other companies.
Frequently asked questions
- What does Paulex Bio do?
- Paulex Bio is developing an oral medicine aimed at regenerating beta cells to address the underlying cause of type 1 and type 2 diabetes. The company works in the biotech and therapeutics space with a goal of a functional cure for diabetes.
- Who are Paulex Bio's investors?
- Paulex Bio's investors include Lifespan Vision Ventures.
- How much funding has Paulex Bio raised?
- Paulex Bio has disclosed $18.5M raised across 1 round.
- Where is Paulex Bio headquartered?
- Paulex Bio is headquartered in La Jolla, US.